Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Open, Classified

TheraSphere Administration Set, REF OTT-SPE-FP-226 (990226.SPE)

FDA Recall Z-2327-2021 · Posted 2021-08-19

Recalling FirmBoston Scientific Corporation
Recall StatusOpen, Classified
Product CodeNAW
Date Initiated2021-07-23
Product Quantity4980 sets

Reason for Recall

Potential for leaks and loosening at the patient catheter connection

Firm Action

The firm disseminated a Medical Device Product Advisory on 07/23/2021 by overnight mail delivery. The letter explained the issue and directed users to ensure a firm connection is made between the outlet luer and the patient catheter prior to, and during ThersSphere administration.

Root Cause

Component change control

Distribution Pattern

Worldwide distribution - US Nationwide and the countries of Belgium, Canada, Germany, Spain, France, United Kingdom/Great Britain, Hong Kong, Ireland, Israel, India, Italy, Netherlands, Poland, Portugal, Saudi Arabia, Singapore, Switzerland, Turkey, and Argentina.

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑